Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 16 to 30 of 118 results for uti

  1. Complicated urinary tract infections: ceftolozane/tazobactam (ESNM74)

    Summary of the evidence on ceftolozane/tazobactam for treating complicated urinary tract infections to inform local NHS planning and decision-making

    Evidence summary
    Published
    9 June 2016

  2. Symptoms and signs of long-term (chronic) UTI: What symptoms and signs do children and young people with long-term (chronic) UTI report and what do they perceive is the impact on their health and quality of life?

    and signs of long-term (chronic) UTI: What symptoms and signs do children and young people with long-term (chronic) UTI...

    Research recommendation
    Published
    4 August 2022

  3. Symptoms and signs of urinary tract infection in children and young people aged 5 years and above but under 16 years: What are the symptoms and signs of urinary tract infection (UTI) in children and young people aged 5 years and above but under 16 years?

    Recommendation ID NG224/01 Question Symptoms and signs of urinary tract infection in children and young people aged 5 years and above...

    Research recommendation
    Published
    4 August 2022

  4. Pentosan polysulfate sodium for treating bladder pain syndrome (TA610)

    Evidence-based recommendations on pentosan polysulfate sodium (Elmiron) for bladder pain syndrome in adults.

    Technology appraisal guidance
    Published
    13 November 2019
    View recommendations

    Sections for TA610

  5. Long-term risk of renal scarring and impaired renal function: A well designed cohort study investigating long-term outcomes including renal scarring and renal function of children who have had UTI should be conducted in the UK.

    children who have had UTI should be conducted in the UK. Any explanatory notes(if applicable) Urinary tract infection and...

    Research recommendation
    Published
    4 August 2022

  6. BladderScan BVI 9400 3D portable ultrasound scanner for measuring bladder volume (MIB50)

    NICE has developed a medtech innovation briefing (MIB) on the BladderScan BVI 9400 3D portable ultrasound scanner for measuring bladder volume

    Medtech innovation briefing
    Published
    22 January 2016

  7. Urinary incontinence in neurological disease: assessment and management (CG148)

    This guideline covers assessing and managing urinary incontinence in children, young people and adults with neurological disease. It aims to improve care by recommending specific treatments based on what symptoms and neurological conditions people have.

    Clinical guideline
    Last updated
    2 October 2023
    View recommendations

    Sections for CG148

  8. Lower urinary tract symptoms in men: management (CG97)

    This guideline covers managing lower urinary tract symptoms (LUTS) in men over 18. It aims to improve the quality of life for men with LUTS by recommending which assessments they should receive, and when conservative management, drug treatment and surgery can help.

    Clinical guideline
    Last updated
    3 June 2015
    View recommendations

    Sections for CG97

  9. Gastro-oesophageal reflux disease in children and young people: diagnosis and management (NG1)

    This guideline covers diagnosing and managing gastro-oesophageal reflux disease in children and young people (under 18s). It aims to raise awareness of symptoms that need investigating and treating, and to reassure parents and carers that regurgitation is common in infants under 1 year.

    NICE guideline
    Last updated
    9 October 2019
    View recommendations

    Sections for NG1

  10. The NGAL Test for early diagnosis of acute kidney injury (MIB3)

    NICE has developed a medtech innovation briefing (MIB) on the NGAL Test for early diagnosis of acute kidney injury .

    Medtech innovation briefing
    Published
    4 February 2014

  11. Management strategies to reduce the risk of symptomatic urinary tract infections:- In people with neurogenic lower urinary tract dysfunction, which management strategies (including the use of prophylactic antibiotics and various invasive and non-invasive techniques to aid bladder drainage) reduce the risk of symptomatic urinary tract infections?

    Question Management strategies to reduce the risk of symptomatic urinary tract infections:- In people with neurogenic lower urinary...

    Research recommendation
    Published
    9 June 2015

  12. Healthcare-associated infections: prevention and control in primary and community care (CG139)

    This guideline covers preventing and controlling healthcare-associated infections in children, young people and adults in primary and community care settings. It provides a blueprint for the infection prevention and control precautions that should be applied by everyone involved in delivering NHS care and treatment.

    Clinical guideline
    Last updated
    15 February 2017
    View recommendations

    Sections for CG139

  13. More research is recommended on UroShield for preventing catheter associated urinary tract infections (UTIs). It has potential to provide significant patient and healthcare system benefits but uncertainties in the evidence need to be addressed. Research should be comparative, and it should address uncertainties about the effectiveness of UroShield in preventing catheter-associated UTIs and other catheter-related complaints such as blockages. Find out more in the further research section of this guidance.

    recommended on UroShield for preventing catheter associated urinary tract infections (UTIs). It has potential to provide...

    Research recommendation
    Published
    8 April 2022

  14. Indwelling urinary catheters: antibiotic prophylaxis:- When recatheterising patients who have a long-term indwelling urinary catheter, what is the clinical and cost effectiveness of single-dose antibiotic prophylaxis in reducing symptomatic urinary tract infections in patients with a history of urinary tract infections associated with catheter change?

    prophylaxis in reducing symptomatic urinary tract infections in patients with a history of urinary tract infections...

    Research recommendation
    Published
    9 June 2015

  15. Gastro-oesophageal reflux in children and young people (QS112)

    This quality standard covers managing symptoms of reflux (regurgitation or bringing up feeds) in babies, children and young people (under 18). It also covers diagnosing and managing gastro-oesophageal reflux disease (also called GORD), which is more severe reflux and heartburn. It describes high-quality care in priority areas for improvement.

    Quality standard
    Published
    28 January 2016
    View quality statements

    Sections for QS112